About
Generics
Areas of Focus
Categories
Generic DrugJapan
Clinical Trials (18)
View allTotal Trials
18
As Lead Sponsor
12
As Collaborator
6
Total Enrollment
1,400
By Phase
PHASE3: 4PHASE1: 8PHASE2: 6
By Status
COMPLETED: 18
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT03372200Collaborator
Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
PHASE3Completed
203 participants
Started: Jan 9, 2018 · Completed: Jul 5, 2018
NCT03375632Collaborator
Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)
PHASE1Completed
26 participants
Started: Jan 4, 2018 · Completed: Jun 5, 2018
NCT03350373Collaborator
Clinical Pharmacology of FYU-981 (Final Formulation)
PHASE1Completed
12 participants
Started: Nov 6, 2017 · Completed: Nov 29, 2017
NCT03350386Collaborator
Drug-drug Interaction Study of FYU-981 and Oxaprozin
PHASE1Completed
12 participants
Started: Nov 2, 2017 · Completed: Dec 5, 2017
NCT03345316Lead Sponsor
Study of FFI-1010 in Pediatric Kidney Disease
PHASE3Completed
60 participants
Started: Nov 1, 2017 · Completed: Nov 1, 2019
Locations (1)
Headquarters
Saitama, Japan
Map
Loading map...